Last 12 months
Inside the activity.
16 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 5 | 0 |
| Dec 2025 | 7 | 0 |
| Jan 2026 | 4 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2021 Filed Mar 10, 2021 21:18 UTC |
Riebman JeromeCHIEF MEDICAL OFFICER
|
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 18,750 | $0.00 Strike: $14.53 | $0.00 |
DisclosureSEC source: 0001104659-21-034460 · tm219212-3_4seq1.xml · derivative · entry 1 Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: CLASS A COMMON STOCK · 18,750 shares Expires 2031-03-08 F1 · derivative.exercise_date: This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:17 UTC |
Roberts DarrylEVP, OPERATIONS & PRODUCT DEV.
|
GrantRESTRICTED STOCK UNITS · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-034455 · tm219212-2_4seq1.xml · derivative · entry 2 Roberts Darryl · CIK 0001825892 · EVP, OPERATIONS & PRODUCT DEV. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: CLASS A COMMON STOCK · 3,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:17 UTC |
Roberts DarrylEVP, OPERATIONS & PRODUCT DEV.
|
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 22,500 | $0.00 Strike: $14.53 | $0.00 |
DisclosureSEC source: 0001104659-21-034455 · tm219212-2_4seq1.xml · derivative · entry 1 Roberts Darryl · CIK 0001825892 · EVP, OPERATIONS & PRODUCT DEV. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: CLASS A COMMON STOCK · 22,500 shares Expires 2031-03-08 F1 · derivative.exercise_date: This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 21:48 UTC |
Mills C RandalDirector
|
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 14,307 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-134244 · tm2038235d2_4.xml · derivative · entry 1 Mills C Randal · CIK 0001370939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,307 Underlying: CLASS A COMMON STOCK · 14,307 shares Expires 2030-12-08 F1 · derivative.exercise_date: This option vests and becomes exercisable in three equal installments on each of October 8, 2021, 2022 and 2023. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 21:42 UTC |
Makes BrigidDirector
|
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 14,307 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-134237 · tm2038235-1_4seq1.xml · derivative · entry 1 Makes Brigid · CIK 0001375927 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,307 Underlying: CLASS A COMMON STOCK · 14,307 shares Expires 2030-12-08 F1 · derivative.exercise_date: This option vests and becomes exercisable in three equal installments on each of October 8, 2021, 2022 and 2023. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 21:50 UTC |
Jordan MaybelleDirector
|
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 14,307 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-134246 · tm2038235-3_4seq1.xml · derivative · entry 1 Jordan Maybelle · CIK 0001826123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,307 Underlying: CLASS A COMMON STOCK · 14,307 shares Expires 2030-12-08 F1 · derivative.exercise_date: This option vests and becomes exercisable in three equal installments on each of October 8, 2021, 2022 and 2023. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 01:57 UTC |
HighCape Capital, L.P.10% owner
HIGHCAPE PARTNERS, L.P.10% owner
HIGHCAPE PARTNERS QP, L.P.10% owner
HighCape Partners GP, LLC10% owner
HighCape Partners GP, L.P.10% owner
HighCape Capital, LLC10% owner
Zuga MattDirector · 10% owner
RAKIN KEVINDirector · 10% owner
|
OtherWarrant · Derivative | 7,655 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001104659-20-114637 · a4.xml · derivative · entry 7 HighCape Capital, L.P. · CIK 0001826279 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 7,655 shares Expires 2027-03-01 F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. F4 · ownership.nature: HighCape Partners QP, L.P. is the record holder of these securities. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 01:57 UTC |
HighCape Capital, L.P.10% owner
HIGHCAPE PARTNERS, L.P.10% owner
HIGHCAPE PARTNERS QP, L.P.10% owner
HighCape Partners GP, LLC10% owner
HighCape Partners GP, L.P.10% owner
HighCape Capital, LLC10% owner
Zuga MattDirector · 10% owner
RAKIN KEVINDirector · 10% owner
|
ConversionSeries A Convertible Preferred Stock · Derivative | 31,133,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-114637 · a4.xml · derivative · entry 6 HighCape Capital, L.P. · CIK 0001826279 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 4,062,451 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering. In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering). F6 · derivative.exercise_date: Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering. In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering). F6 · derivative.expiration_date: Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering. In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering). F1 · ownership.nature: Consists of (i) 43,255 shares of Class A common stock held by HighCape Partners, L.P.; (ii) 3,211,838 shares of Class A common stock held by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A common stock held by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A common stock held by HighCape Co-Investment Vehicle II, LLC and (v) 48,931 shares of Class A common stock held by HighCape Capital, L.P. F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. F3 · ownership.nature: In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 01:57 UTC |
HighCape Capital, L.P.10% owner
HIGHCAPE PARTNERS, L.P.10% owner
HIGHCAPE PARTNERS QP, L.P.10% owner
HighCape Partners GP, LLC10% owner
HighCape Partners GP, L.P.10% owner
HighCape Capital, LLC10% owner
Zuga MattDirector · 10% owner
RAKIN KEVINDirector · 10% owner
|
PurchaseClass A Common Stock | 441,176 | $17.00 | $7,499,992.00 |
DisclosureSEC source: 0001104659-20-114637 · a4.xml · nonDerivative · entry 4 HighCape Capital, L.P. · CIK 0001826279 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 4,508,831 F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. F3 · ownership.nature: In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. F5 · ownership.nature: Consists of (i) 49,118 shares of Class A common stock held by HighCape Partners, L.P.; (ii) 3,652,355 shares of Class A common stock held by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A common stock held by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A common stock held by HighCape Co-Investment Vehicle II, LLC and (v) 48,931 shares of Class A common stock held by HighCape Capital, L.P. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 01:57 UTC |
HighCape Capital, L.P.10% owner
HIGHCAPE PARTNERS, L.P.10% owner
HIGHCAPE PARTNERS QP, L.P.10% owner
HighCape Partners GP, LLC10% owner
HighCape Partners GP, L.P.10% owner
HighCape Capital, LLC10% owner
Zuga MattDirector · 10% owner
RAKIN KEVINDirector · 10% owner
|
Tax withholdingClass A Common Stock | 2,451 | $5.44 | $13,339.32 |
DisclosureSEC source: 0001104659-20-114637 · a4.xml · nonDerivative · entry 3 HighCape Capital, L.P. · CIK 0001826279 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 4,067,655 F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. F3 · ownership.nature: In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. F4 · ownership.nature: HighCape Partners QP, L.P. is the record holder of these securities. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 01:57 UTC |
HighCape Capital, L.P.10% owner
HIGHCAPE PARTNERS, L.P.10% owner
HIGHCAPE PARTNERS QP, L.P.10% owner
HighCape Partners GP, LLC10% owner
HighCape Partners GP, L.P.10% owner
HighCape Capital, LLC10% owner
Zuga MattDirector · 10% owner
RAKIN KEVINDirector · 10% owner
|
OtherClass A Common Stock | 7,655 | $5.44 | $41,661.57 |
DisclosureSEC source: 0001104659-20-114637 · a4.xml · nonDerivative · entry 2 HighCape Capital, L.P. · CIK 0001826279 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 4,070,106 F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. F3 · ownership.nature: In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. F4 · ownership.nature: HighCape Partners QP, L.P. is the record holder of these securities. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 01:57 UTC |
HighCape Capital, L.P.10% owner
HIGHCAPE PARTNERS, L.P.10% owner
HIGHCAPE PARTNERS QP, L.P.10% owner
HighCape Partners GP, LLC10% owner
HighCape Partners GP, L.P.10% owner
HighCape Capital, LLC10% owner
Zuga MattDirector · 10% owner
RAKIN KEVINDirector · 10% owner
|
ConversionClass A Common Stock | 4,062,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-114637 · a4.xml · nonDerivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 4,062,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Consists of (i) 43,255 shares of Class A common stock held by HighCape Partners, L.P.; (ii) 3,211,838 shares of Class A common stock held by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A common stock held by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A common stock held by HighCape Co-Investment Vehicle II, LLC and (v) 48,931 shares of Class A common stock held by HighCape Capital, L.P. F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. F3 · ownership.nature: In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. Read SEC document |
| October 13, 2020 Filed Oct 13, 2020 21:57 UTC |
LLOYD RONALD K.Director · President and CEO
|
ConversionSeries A Convertible Preferred Stock · Derivative | 111,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-114635 · a4.xml · derivative · entry 2 LLOYD RONALD K. · CIK 0001644078 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 14,586 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering. In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering). F1 · derivative.exercise_date: Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering. In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering). F1 · derivative.expiration_date: Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering. In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering). Read SEC document |
| October 13, 2020 Filed Oct 13, 2020 21:57 UTC |
LLOYD RONALD K.Director · President and CEO
|
ConversionClass A Common Stock | 14,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-114635 · a4.xml · nonDerivative · entry 1 LLOYD RONALD K. · CIK 0001644078 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 20:27 UTC |
Ferguson MatthewChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 81,800 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113578 · a4.xml · derivative · entry 1 Ferguson Matthew · CIK 0001304079 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,800 Underlying: Class A Common Stock · 81,800 shares Expires 2030-10-06 F1 · derivative.exercise_date: This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 20:27 UTC |
LLOYD RONALD K.Director · President and CEO
|
GrantRestricted Stock Units · Derivative | 100,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113579 · a4.xml · derivative · entry 2 LLOYD RONALD K. · CIK 0001644078 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,425 Underlying: Class A Common Stock · 100,425 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. F3 · derivative.expiration_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 20:27 UTC |
LLOYD RONALD K.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 181,783 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113579 · a4.xml · derivative · entry 1 LLOYD RONALD K. · CIK 0001644078 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,783 Underlying: Class A Common Stock · 181,783 shares Expires 2030-10-06 F1 · derivative.exercise_date: This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:28 UTC |
Riebman JeromeChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 10,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113580 · a4.xml · derivative · entry 2 Riebman Jerome · CIK 0001825821 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,186 Underlying: Class A Common Stock · 10,186 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. F3 · derivative.expiration_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:28 UTC |
Riebman JeromeChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 30,412 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113580 · a4.xml · derivative · entry 1 Riebman Jerome · CIK 0001825821 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,412 Underlying: Class A Common Stock · 30,412 shares Expires 2030-10-06 F1 · derivative.exercise_date: This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:27 UTC |
Englese ThomasChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 13,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113577 · a4.xml · derivative · entry 2 Englese Thomas · CIK 0001825799 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,890 Underlying: Class A Common Stock · 13,890 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. F3 · derivative.expiration_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:27 UTC |
Englese ThomasChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 33,488 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113577 · a4.xml · derivative · entry 1 Englese Thomas · CIK 0001825799 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,488 Underlying: Class A Common Stock · 33,488 shares Expires 2030-10-06 F1 · derivative.exercise_date: This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:26 UTC |
Roberts DarrylEVP, Operations & Product Deve
|
GrantRestricted Stock Units · Derivative | 11,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113576 · a4.xml · derivative · entry 2 Roberts Darryl · CIK 0001825892 · EVP, Operations & Product Deve 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,112 Underlying: Class A Common Stock · 11,112 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. F3 · derivative.expiration_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:26 UTC |
Roberts DarrylEVP, Operations & Product Deve
|
GrantStock Option (Right to Buy) · Derivative | 50,083 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113576 · a4.xml · derivative · entry 1 Roberts Darryl · CIK 0001825892 · EVP, Operations & Product Deve 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,083 Underlying: Class A Common Stock · 50,083 shares Expires 2030-10-06 F1 · derivative.exercise_date: This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.